Etravirine adverse reactions: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
Line 7: | Line 7: | ||
The following adverse reactions are described in greater detail in other sections: | The following adverse reactions are described in greater detail in other sections: | ||
Severe skin and hypersensitivity reactions [[Etravirine warnings and precautions|see Warnings and Precautions]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = INTELENCE (ETRAVIRINE) TABLET [JANSSEN PRODUCTS LP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a9cbc29-9f15-4b24-8d86-206b82887f3d | publisher = | date = | accessdate = }}</ref> | Severe skin and hypersensitivity reactions ([[Etravirine warnings and precautions|see Warnings and Precautions]]).<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = INTELENCE (ETRAVIRINE) TABLET [JANSSEN PRODUCTS LP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a9cbc29-9f15-4b24-8d86-206b82887f3d | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== |
Revision as of 19:25, 2 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Adverse Reactions
The following adverse reactions are described in greater detail in other sections:
Severe skin and hypersensitivity reactions (see Warnings and Precautions).[1]
References
Adapted from the FDA Package Insert.